Surgical management of transvenous lead-induced tricuspid regurgitation in adult and pediatric patients with congenital heart disease Dec. 26, 2022 Overview Show transcript Overview Juan A. Crestanello, M.D., is a cardiovascular surgeon and department chair of Cardiovascular Surgery at Mayo Clinic in Rochester, Minnesota. Dr. Crestanello, who specializes in surgery for valvular heart disease, discusses surgical management of transvenous lead-induced tricuspid regurgitation in adult and pediatric patients with congenital heart disease. Receive Mayo Clinic news in your inbox. Sign up Related ContentArticleIncidence and burden of tricuspid regurgitation in patients with atrial fibrillationVideoOutcomes of tricuspid valve surgery in patients with functional tricuspid regurgitation VID-20544817 Medical Professionals Surgical management of transvenous lead-induced tricuspid regurgitation in adult and pediatric patients with congenital heart disease